20MG/10MG TBL NOB 30

Maximum ex-factory price/Ex-factory price ? 966,66 CZK
Legal basis of maximum ex-factory price/ex-factory price ? Maximum ex-factory price announced under the law.

Informace o základní úhradě

Core reimbursement from health insurance ? 335,66 CZK
Maximum reimbursement from health insurance ? 494,14 CZK
Legal basis of reimbursement from health insurance ? Reimbursement set by the law.
Indication restriction of reimbursement ? Fixní kombinace ezetimib a rosuvastatin je hrazena u pacientů, u kterých nelze dosáhnout cílových hodnot LDL-cholesterolu atorvastatinem 20,00 mg/den, simvastatinem 40,00 mg/den, fluvastatinem 80,00 mg/den, lovastatinem 80,00 mg/den a pravastatinem 40,00 mg/den nebo rosuvastatinem 20,00 mg/den. Cílová hodnota je stanovena u osob bez manifestace aterosklerózy či diabetu na 3,00 mmol/l a u osob s manifestací aterosklerózy či diabetem na 2,50 mmol/l. Fixní kombinace ezetimib a rosuvastatin je hrazena u pacientů, kteří jsou již dostatečně léčeni ezetimibem a rosuvastatinem podávanými samostatně.
Prescribing doctor's specialisation ? Cardiology; child cardiology; angiology
Specialised facility for treatment of hyperlipoproteinemia
Internal medicine
Reporting limit ? E: Unless it is advisable to transfer the prescription of the product to another doctor under paragraph 2 in light of the effect and safety of the product, the "E" symbol will mark the product in the decision.
Rough price for the final consumer ? 1334,29 CZK
Rough payment for the final consumer (for 1 prescribed package dispensed) ? 840.15 CZK
Eligible extra payment ?
Eligible extra payment for individuals aged 65 and older ?
Medicinal products reimbursed from health insurance contain the amount of the maximum manufacturer´s price or the producer´s notified price for products which are not subjected to the regulation of the maximum manufacturer´s price, the amount of reimbursement from health insurance and the estimated price for the end consumer (pharmacy price).

Back to list